Advertisement Aragon Surgical raises $25 million in series B financing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Aragon Surgical raises $25 million in series B financing

Aragon Surgical, a developer of surgical devices, has completed $25 million private equity financing.

The series B financing was led by Bay City Capital and included Integral Capital Partners as well as current investors Delphi Ventures and Onset Ventures.

Peter Edelstein, president and CEO of Aragon Surgical, said: “Along with our current top-tier investors, our new investors bring tremendous experience at a critical time in our company’s history, with the recent launch of our first product and with several additional products in development.”